Published • loading... • Updated
Pharmaceutical Company Inaugurates Solar Park in Canóvanas
Summary by El Vocero De Puerto Rico
2 Articles
2 Articles
With an investment of $9.7 million, iPR Pharmaceuticals inaugurated the Bio Solar Park, a new photovoltaic panel park in Canóvanas.
AstraZeneca's subsidiary invests $9.7 million in solar park in Canóvanas Photo supplied By Editor of Sin Comillas Today, the Bio Solar Park of iPR Pharmaceuticals, a subsidiary of AstraZeneca, was inaugurated in Canóvanas, which required an investment of $9.7 million and received incentives from the government. The solar park has 3,709 solar panels and a 2 megawatt (MW) battery system that will reduce greenhouse gas emissions by 173 tons per yea…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
